stars 1 stars 2 stars 3

Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including movement disorders, autism spectrum disorders, depression and pain.

Neurolixis Questions

The Neurolixis annual revenue was $4 million in 2026.

Adrian Newman-Tancredi is the Co-Founder and Chief Executive Officer of Neurolixis.

5 people are employed at Neurolixis.

Neurolixis is based in Park Ridge, New Jersey.

The NAICS codes for Neurolixis are [54171, 54, 5417, 32, 325, 541711, 541].

The SIC codes for Neurolixis are [87, 873].

Top Neurolixis Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users